Literature DB >> 32690658

Myeloid Cell-Intrinsic IRF5 Promotes T Cell Responses through Multiple Distinct Checkpoints In Vivo, and IRF5 Immune-Mediated Disease Risk Variants Modulate These Myeloid Cell Functions.

Jie Yan1, Matija Hedl1, Clara Abraham2.   

Abstract

Common IRF5 genetic risk variants associated with multiple immune-mediated diseases are a major determinant of interindividual variability in pattern-recognition receptor (PRR)-induced cytokines in myeloid cells. However, how myeloid cell-intrinsic IRF5 regulates the multiple distinct checkpoints mediating T cell outcomes in vivo and IRF5-dependent mechanisms contributing to these distinct checkpoints are not well defined. Using an in vivo Ag-specific adoptive T cell transfer approach into Irf5-/- mice, we found that T cell-extrinsic IRF5 regulated T cell outcomes at multiple critical checkpoints, including chemokine-mediated T cell trafficking into lymph nodes and PDK1-dependent soluble Ag uptake, costimulatory molecule upregulation, and secretion of Th1 (IL-12)- and Th17 (IL-23, IL-1β, and IL-6)-conditioning cytokines by myeloid cells, which then cross-regulated Th2 and regulatory T cells. IRF5 was required for PRR-induced MAPK and NF-κB activation, which, in turn, regulated these key outcomes in myeloid cells. Importantly, mice with IRF5 deleted from myeloid cells demonstrated T cell outcomes similar to those observed in Irf5-/- mice. Complementation of IL-12 and IL-23 was able to restore T cell differentiation both in vitro and in vivo in the context of myeloid cell-deficient IRF5. Finally, human monocyte-derived dendritic cells from IRF5 disease-associated genetic risk carriers leading to increased IRF5 expression demonstrated increased Ag uptake and increased PRR-induced costimulatory molecule expression and chemokine and cytokine secretion compared with monocyte-derived dendritic cells from low-expressing IRF5 genetic variant carriers. These data establish that myeloid cell-intrinsic IRF5 regulates multiple distinct checkpoints in T cell activation and differentiation and that these are modulated by IRF5 disease risk variants.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32690658      PMCID: PMC7498241          DOI: 10.4049/jimmunol.1900743

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

1.  CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs.

Authors:  R Förster; A Schubel; D Breitfeld; E Kremmer; I Renner-Müller; E Wolf; M Lipp
Journal:  Cell       Date:  1999-10-01       Impact factor: 41.582

2.  Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity.

Authors:  Elise Dalmas; Amine Toubal; Fawaz Alzaid; Katrina Blazek; Hayley L Eames; Kristell Lebozec; Maria Pini; Isabelle Hainault; Emilie Montastier; Raphaël G P Denis; Patricia Ancel; Amélie Lacombe; Yin Ling; Omran Allatif; Céline Cruciani-Guglielmacci; Sébastien André; Nathalie Viguerie; Christine Poitou; Vladimir Stich; Alexandra Torcivia; Fabienne Foufelle; Serge Luquet; Judith Aron-Wisnewsky; Dominique Langin; Karine Clément; Irina A Udalova; Nicolas Venteclef
Journal:  Nat Med       Date:  2015-05-04       Impact factor: 53.440

3.  IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses.

Authors:  Thomas Krausgruber; Katrina Blazek; Tim Smallie; Saba Alzabin; Helen Lockstone; Natasha Sahgal; Tracy Hussell; Marc Feldmann; Irina A Udalova
Journal:  Nat Immunol       Date:  2011-01-16       Impact factor: 25.606

Review 4.  Interferon regulatory factor 5 in human autoimmunity and murine models of autoimmune disease.

Authors:  Hayley L Eames; Alastair L Corbin; Irina A Udalova
Journal:  Transl Res       Date:  2015-07-04       Impact factor: 7.012

5.  IRF5 distinguishes severe asthma in humans and drives Th1 phenotype and airway hyperreactivity in mice.

Authors:  Timothy B Oriss; Mahesh Raundhal; Christina Morse; Rachael E Huff; Sudipta Das; Rachel Hannum; Marc C Gauthier; Kathryn L Scholl; Krishnendu Chakraborty; Seyed M Nouraie; Sally E Wenzel; Prabir Ray; Anuradha Ray
Journal:  JCI Insight       Date:  2017-05-18

6.  Functional characterization of murine interferon regulatory factor 5 (IRF-5) and its role in the innate antiviral response.

Authors:  Andrea Paun; Jorgen T Reinert; Zhaozhao Jiang; Carey Medin; Mumtaz Yaseen Balkhi; Katherine A Fitzgerald; Paula M Pitha
Journal:  J Biol Chem       Date:  2008-03-10       Impact factor: 5.157

7.  T cells down-regulate macrophage TNF production by IRAK1-mediated IL-10 expression and control innate hyperinflammation.

Authors:  Makoto Inoue; Tomohiro Arikawa; Yu-Hsun Chen; Yasuhiro Moriwaki; Michael Price; Michael Brown; John R Perfect; Mari L Shinohara
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-21       Impact factor: 11.205

8.  Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection.

Authors:  Andrea Paun; Rashmi Bankoti; Trupti Joshi; Paula M Pitha; Simona Stäger
Journal:  PLoS Pathog       Date:  2011-01-06       Impact factor: 6.823

9.  6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7.

Authors:  J J Campbell; E P Bowman; K Murphy; K R Youngman; M A Siani; D A Thompson; L Wu; A Zlotnik; E C Butcher
Journal:  J Cell Biol       Date:  1998-05-18       Impact factor: 10.539

10.  Inflammation induces two types of inflammatory dendritic cells in inflamed lymph nodes.

Authors:  Jiyoun Min; Dongchan Yang; Mirang Kim; Keeok Haam; Anji Yoo; Jae-Hoon Choi; Barbara U Schraml; Yong Sung Kim; Dongsup Kim; Suk-Jo Kang
Journal:  Exp Mol Med       Date:  2018-03-16       Impact factor: 8.718

View more
  2 in total

Review 1.  Harnessing Tolerogenic Histone Peptide Epitopes From Nucleosomes for Selective Down-Regulation of Pathogenic Autoimmune Response in Lupus (Past, Present, and Future).

Authors:  Syamal K Datta
Journal:  Front Immunol       Date:  2021-04-14       Impact factor: 7.561

Review 2.  Involvement of Interleukin-1 Receptor-Associated Kinase 4 and Interferon Regulatory Factor 5 in the Immunopathogenesis of SARS-CoV-2 Infection: Implications for the Treatment of COVID-19.

Authors:  Nicholas Stoy
Journal:  Front Immunol       Date:  2021-04-07       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.